Common Uses and Benefits Semaglutide is primarily used to treat type 2 diabetes, a condition where the body either doesnt produce enough insulin or becomes resistant to it
Doctors and patients need to be thinking about how to treat the whole person, rather than count on the new treatments, promising though they may be, to act as miracle drugs
Lancet London, England 384 (9951), 13491357
Clinical evidence shows semaglutide users lose primarily fat when protein intake is adequate (1.21.6 g/kg body weight) and resistance training is performed regularly
Estrogen decline affects ghrelin and leptin signaling, making hunger harder to ignore and satiety signals weaker
Analysis of pooled phase II and phase III RCTs that describes the albuminuria-lowering effect of dulaglutide compared to insulin glargine and other active comparators beyond glycaemic control